OncoStem was recognised for its innovative AI-based prognostic test ‘CanAssist Breast’
OncoStem Diagnostics, an oncology focussed company that enables personalised cancer treatment has been recognised as the winner of Aegis Graham Bell Award in the Innovative Diagnostics Category. The award is an initiative by Aegis School of Data Science to honour innovations in IT, Telecom and exponential technologies.
Aegis Graham Bell Award is a tribute to the father of telephony and great innovator, Alexander Graham Bell. The Aegis School of Business, Data Science and Cyber Security has initiated this award to promote innovations and recognise the outstanding contributions by the innovators. This award is supported by the Ministry of Electronics and Information Technology, Government of India; NITI Aayog (National Institution for Transforming India is a policy think tank of the Government of India); Skill India (campaign launched by Prime Minister of India, Narendra Modi, the campaign is under Ministry of Skill Development and Entrepreneurship); National Informatics Centre Services Incorporated (NICSI), a Government of India enterprise.
Commenting on the recognition, Dr Manjiri Bakre, CEO and Founder, OncoStem said, “We are honoured to be recognised as winners in the category of innovative diagnostics. At OncoStem, innovation is not just an idea/concept, it’s a process that we have followed at every stage of the product. This award is a huge recognition of our exemplary teamwork and we hope this award will help us in our goal to reach every eligible breast cancer patient in India via our government’s universal health scheme – Ayushman Bharat. More importantly, I hope this award given to many start-ups like ours will help India achieve its goal to become “Aatmanirbhar Bharat” as a nation.
OncoStem’s CanAssist Breast is an innovative, cost-effective test that can help clinicians to plan tailor-made treatment for each breast cancer patient based on tumour biology.